XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenue $ 9,167 $ 6,457
Cost of goods sold 1,495 971
Gross profit 7,672 5,486
Operating expenses:    
Research and development 3,296 5,844
Sales and marketing 6,734 6,687
General and administrative 4,971 4,627
Loss from operations (7,329) (11,672)
Other income (expense):    
Interest income 74 92
Interest expense (1,209) (3)
Change in fair value of SEPA, warrant, and revenue base redemption liabilities (835) 2,521
Change in fair value of contingent earnout liability (820) (3,988)
Other expense, net (251) (153)
Loss before income taxes (10,370) (13,203)
Income tax expense (5) (3)
Net loss available to common stockholders (10,375) (13,206)
Undeclared dividends on Series A preferred stock (712) (801)
Net loss attributable to common stockholders $ (11,087) $ (14,007)
Net loss per common share, basic (in dollars per share) $ (0.39) $ (0.60)
Net loss per common share, diluted (in dollars per share) $ (0.39) $ (0.60)
Weighted average common shares outstanding, basic (in shares) 28,527,453 23,323,045
Weighted average common shares outstanding, diluted (in shares) 28,527,453 23,323,045